Liraglutide, an agonist of the glucagon-like peptide-1 (GLP-1) receptor, likewise demonstrated strong neuroprotective effects in animal models of Parkinson's disease
Therapeutic potential of semaglutide, a newer GLP-1 receptor agonist, in abating obesity, non-alcoholic steatohepatitis and neurodegenerative diseases: a narrative review
However, it may cover weight loss surgery, like gastric bypass or sleeve gastrectomy, if you meet certain health and BMI requirements
Additionally, staying hydrated and avoiding large meals after taking the medication can help alleviate nausea
However, increasing protein intake may help reduce this risk
However, the volume and severity of recent complaints have escalated concerns about legal accountability for unsafe and misbranded versions of GLP-1 drugs